Grown Rogue International (GRUSF) Net Income towards Common Stockholders (QoQ) (2009 - 2026)
Grown Rogue International (GRUSF) Net Income towards Common Stockholders (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | -319.19% |
| Sep 30, 2025 | 204,305,104.63% |
| Sep 30, 2024 | 89.59% |
| Oct 31, 2023 | -857.96% |
| Jul 31, 2023 | -50.30% |
| Apr 30, 2023 | -55.70% |
| Jul 31, 2021 | 95.24% |
| Apr 30, 2021 | -6.42% |
| Jan 31, 2021 | -4,185.53% |
| Oct 31, 2020 | 103.30% |
| Jul 31, 2020 | 38.09% |
| Apr 30, 2020 | 19.86% |
| Jan 31, 2020 | 22.93% |
| Oct 31, 2019 | -172.61% |
| Jul 31, 2019 | 53.55% |
| Apr 30, 2019 | 65.65% |
| Jan 31, 2019 | -91.02% |
| Oct 31, 2018 | -72.02% |
| Aug 31, 2018 | 29.28% |